Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.

Clinical pharmacology and therapeutics - 1 Jul 2006

Schwarz Ute I, Stein C Michael

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acenocoumarol
Share to Administration, Oral
Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Mixed Function Oxygenases

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 16815312
DOI: 10.1016/j.clpt.2006.04.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.PMID 16815312Read ↗

Genetic and clinical factors relating to warfarin dosingSemantic proximity Read ↗

Genetics of warfarin dosing--one polymorphism at a time.Semantic proximity Read ↗

Genetic susceptibility to hemorrhagic complications during warfarin therapy.Semantic proximity Read ↗

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.Semantic proximity Read ↗

Anticoagulation therapy: genotype-guided anticoagulation therapy-the jury is still out.Semantic proximity Read ↗

Warfarin sensitivity and genetic polymorphisms: should pharmacokinetic screening be part of anticoagulant dosing decisions?Semantic proximity Read ↗

Use of genetic and nongenetic factors in warfarin dosing algorithms.Semantic proximity Read ↗

[Pharmacogenomics of vitamin K antagonists].Semantic proximity Read ↗

Genotype-guided dosing of warfarin.Semantic proximity Read ↗

Pharmacogenetics of warfarin: challenges and opportunitiesSemantic proximity Read ↗

Pharmacogenetic-based dosing of warfarin.Semantic proximity Read ↗

Exploiting common genetic variation to make anticoagulation safer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.